HYPMYHypera SA

About Hypera SA (HYPMY)

Hypera SA (HYPMY) is a Drug Manufacturers - Specialty & Generic company headquartered in Sao Paulo, Brazil whose shares trade over-the-counter on the Pink tier.

Hypera Pharma is one of the largest pharmaceutical companies in Brazil present in all relevant segments of the retail pharmaceutical sector, such as RX, OTC, Generics and Skincare. The Company also offers products to hospitals and clinics and is part of a Joint Venture for biologicals called Bionovis in Brazil.

Products and services

The Company operates in the most important segments of the Brazilian pharmaceutical market. Since the 2016, the Company has been organized into business units. We currently have the four main segments in which we operate in the retail market: (i) Prescription Products, focused on the business of medicines prescribed by the medical community; (ii) Consumer Health, focused mainly on the business of non-prescription medicines; (iii) Similar and Generics, focused on similar and generic medicines under the Neo Química brand; and (iv) Skincare, focused on dermatological products. In 2021, the company announced a new business unit focused on the non-retail market. As of the fiscal year ended December 31, 2016, the Company began a new cycle in its strategic development with an exclusive focus on the Brazilian pharmaceutical market, after completing the important portfolio rotation moves announced in 2015.

HYPMY key facts

Ticker symbol

HYPMY

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Sao Paulo, Brazil

Country of incorporation

BR

Year of incorporation

2011

Employees

10,481

Estimated market cap

$2.15B (as of Apr 9, 2025)

Shares outstanding

633,420,823

Reporting standard

International Reporting: B3 S.A.

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

Hypera SA leadership

• Breno Toledo Pires de Oliveira — Acting CEO
• Juliana Aguinaga Damiao Salem — Officer
• Rafael Vito Batista — Officer
• Ramon Sanches Frutuoso Silva — Acting CFO
• Adalmario Ghovatto Satheler do Couto — IR, Officer
• Gabriel Toshiyuki Otsuka Mauro — IR Analyst
• Douglas Henrique Furlan — IR Manager

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H